-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 1, Dongyang Sunshine issued an announcement stating that its holding subsidiary Yichang Dongyang Sunshine Yangtze River Pharmaceutical Co.
Insulin aspart is a human insulin analogue.
According to the data reported by the International Diabetes Federation in 2019, the number of diabetic patients in mainland China is about 116 million, and the incidence rate among people aged 20-79 is about 10.
So far, Dongyang Sunshine Insulin Aspart Injection has invested approximately RMB 68,618,000 in research and development.